Souhaitez-vous accéder aux communiqués récents ?

Series A financing led by 4BIO Capital, with major new investors Servier Ventures, Sound Bioventures, British Business Bank and Criteria Bio Ventures, supported by existing investors Abingworth and...

This research investment will enable Dr. Jeanette Boudreau to prepare powerful natural killer cell immunotherapy to move into clinical trials

Oncolytics announced new data in metastatic colorectal cancer, demonstrating 3-4x improvement in duration response vs. historical 4-6 month benchmark.

Jeremy B. Fitch, MBA, appointed as Chief Business OfficerMichael A. Alrutz, J.D., Ph.D., appointed as General CounselGuy C. Ruble, PharmD, appointed as VP, Regulatory Affairs CAMBRIDGE, United...

Toronto, Ontario, May 04, 2026 (GLOBE NEWSWIRE) -- Dr. Roger Wong has been selected as the 2026 recipient of the Award for Eminent Contribution to Older Adults in Canada. He will be honoured by the...

Ohio, May 02, 2026 (GLOBE NEWSWIRE) -- Northeast Ohio Medical University (NEOMED) returned to E.J. Thomas Hall for its 46th Commencement Ceremony — a celebration honoring years of dedication,...

A new investigation reveals disturbing conditions and ethically questionable research practices involving monkeys at an Ontario university.

MidAmerica Cancer Care and American Oncology Network Welcome Dr. Syed Karim

LOS ANGELES, April 30, 2026 (GLOBE NEWSWIRE) -- via IBN -- Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB: OTLC), a clinical-stage biotechnology company focused on oncology and...

QUANZHOU, China, April 29, 2026 (GLOBE NEWSWIRE) -- INLIF LIMITED (NASDAQ: INLF) (together with all its subsidiaries and consolidated entities, the “Company” or “INLIF”), a company engaged in the...